Misplaced Pages

Talk:Aspartame controversy/to do: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
< Talk:Aspartame controversy Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 15:29, 30 April 2009 editSV Resolution (talk | contribs)Extended confirmed users1,616 edits allegations of COI in critiques of Soffritti studies← Previous edit Revision as of 08:49, 31 May 2009 edit undoMaxPont (talk | contribs)Extended confirmed users1,757 edits add timeline (it might be forgotten otherwiseNext edit →
Line 6: Line 6:
*Charges of COI in hirings of 6 FDA personnel (described in GAO 86 report to Metzenbaum) *Charges of COI in hirings of 6 FDA personnel (described in GAO 86 report to Metzenbaum)
*Studies by Olney and others dismissed. *Studies by Olney and others dismissed.
*Expand and integrate the timeline in the article
*Charges of COI when new FDA commissioner overturned unanimous decision of PBOI *Charges of COI when new FDA commissioner overturned unanimous decision of PBOI
Senator Metzenbaum's role in returning the controversy to the news. Senator Metzenbaum's role in returning the controversy to the news.

Revision as of 08:49, 31 May 2009


 Here are some tasks awaiting attention:
  • Cleanup : Scientific publications -- weak Gone --SV Resolution(Talk) 15:29, 30 April 2009 (UTC) Alleged conflict of intrerest prior to 1996 -- should this be merged into discussion of approval?
  • Expand : Why the US approval process caused controversy
    • Charges of COI in DOJ handling of FDA's Fraud allegations against Searle.
    • Charges of COI in hirings of 6 FDA personnel (described in GAO 86 report to Metzenbaum)
    • Studies by Olney and others dismissed.
    • Expand and integrate the timeline in the article
    • Charges of COI when new FDA commissioner overturned unanimous decision of PBOI
    Senator Metzenbaum's role in returning the controversy to the news. Why the Ramazzinni studies contribute to the controversy
    • Allegations of COI in industry-funded critiques of Soffritti studies
    ...
  • NPOV : Remember that some parts of this article follow WP:MEDRS and must reflect the preponderance of medical opinion, while other parts of this article follow WP:CONTROVERSY and must explain the controversy.
  • Verify : Different types of sources are appropriate to different sections of this article.